Scarica l'app Stockscreener
28.01
1.30%
0.36
Dopo l'orario di chiusura:
28.01
Precedente Chiudi:
$27.65
Aprire:
$27.55
Volume 24 ore:
226.19K
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.32B
Reddito:
-
Utile/perdita netta:
$-71.58M
Rapporto P/E:
-22.57
EPS:
-1.2413
Flusso di cassa netto:
$-61.42M
1 W Prestazione:
-1.79%
1M Prestazione:
+1.74%
6M Prestazione:
+23.66%
1 anno Prestazione:
+115.46%
Intervallo 1D:
$27.02
$28.04
Intervallo di 1 settimana:
$26.91
$29.09
Portata 52W:
$9.80
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Nome
Enliven Therapeutics Inc
Settore
Industria
Telefono
720-647-8519
Indirizzo
6200 LOOKOUT ROAD, BOULDER
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-03-29 | Iniziato | Jefferies | Buy |
Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie
Jones Trading Initiates Coverage of Enliven Therapeutics (ELVN) with Buy Recommendation - MSN
Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 By Investing.com - Investing.com South Africa
Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 - Investing.com
Enliven Therapeutics (ELVN) Price Target Increased by 10.75% to 35.02 - MSN
Enliven Therapeutics CFO sells $24,422 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CFO sells $24,422 in stock - Investing.com
Enliven Therapeutics chief medical officer sells $24,482 in stock By Investing.com - Investing.com Canada
Enliven Therapeutics chief medical officer sells $24,482 in stock - Investing.com India
Enliven Therapeutics COO Anish Patel sells $21,482 in stock - Investing.com
Enliven Therapeutics COO Anish Patel sells $21,482 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics' chief scientific officer sells $25,412 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CEO Kintz sells $27,722 in stock - Investing.com
Enliven Therapeutics' chief scientific officer sells $25,412 in stock - Investing.com India
Enliven Therapeutics director Heyman sells $47,104 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CEO Kintz sells $27,722 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics director Heyman sells $47,104 in stock - Investing.com India
Anish Patel Sells 716 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
When (ELVN) Moves Investors should Listen - Stock Traders Daily
Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
ELVN stock soars to 52-week high, reaching $28.66 By Investing.com - Investing.com Australia
Enliven Therapeutics (NASDAQ:ELVN) Reaches New 52-Week HighHere's Why - MarketBeat
Richard A. Heyman Sells 1,270 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics Inc [ELVN] Insider Lyssikatos Joseph P sells 37,878 Shares - Knox Daily
Enliven Therapeutics Inc (ELVN) stock analysis: A simple moving average approach - US Post News
Financial Metrics Check: Enliven Therapeutics Inc (ELVN)’s Ratios for Trailing Twelve Months - The Dwinnex
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Update - MarketBeat
Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why - Benzinga
Insider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Sells 10,420 Shares of Stock - MarketBeat
Enliven Therapeutics executive sells over $1.4 million in company stock - Investing.com India
Enliven Therapeutics director sells over $290k in company stock - Investing.com
Enliven Therapeutics director sells over $290k in company stock By Investing.com - Investing.com UK
Enliven Therapeutics (NASDAQ:ELVN) Trading Down 5.6%What's Next? - MarketBeat
Enliven Therapeutics CFO sells over $300k in company stock By Investing.com - Investing.com South Africa
Enliven Therapeutics director sells over $77k in company stock - Investing.com India
Enliven Therapeutics director sells over $77k in company stock By Investing.com - Investing.com Canada
ELVN stock soars to 52-week high, reaching $27.87 By Investing.com - Investing.com South Africa
Richard A. Heyman Sells 2,825 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World
Enliven Therapeutics CFO sells over $300k in company stock - Investing.com
Enliven Therapeutics CEO sells over $410k in company stock By Investing.com - Investing.com South Africa
Enliven Therapeutics CEO sells over $410k in company stock - Investing.com India
Enliven Therapeutics exec sells over $280k in company stock - Investing.com India
Enliven Therapeutics exec sells over $280k in company stock By Investing.com - Investing.com Canada
Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Enliven Therapeutics Inc Azioni (ELVN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Oct 28 '24 |
Sale |
28.56 |
6,250 |
178,485 |
0 |
| Patel Anish | CHIEF OPERATING OFFICER |
Oct 18 '24 |
Sale |
30.00 |
716 |
21,483 |
343,311 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER |
Oct 18 '24 |
Sale |
30.00 |
847 |
25,413 |
1,015,188 |
| Kintz Samuel | PRESIDENT AND CEO |
Oct 18 '24 |
Sale |
30.00 |
924 |
27,723 |
1,002,892 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Oct 18 '24 |
Option Exercise |
2.48 |
814 |
2,019 |
814 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Oct 18 '24 |
Sale |
30.00 |
814 |
24,422 |
0 |
| Heyman Richard A. | Director |
Oct 18 '24 |
Sale |
30.00 |
817 |
24,512 |
123,673 |
| Heyman Richard A. | Director |
Oct 18 '24 |
Sale |
30.00 |
753 |
22,592 |
27,165 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER |
Oct 18 '24 |
Option Exercise |
2.48 |
816 |
2,024 |
816 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER |
Oct 18 '24 |
Sale |
30.00 |
816 |
24,482 |
0 |
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):